000 | 00983 a2200265 4500 | ||
---|---|---|---|
005 | 20250512081046.0 | ||
264 | 0 | _c19851226 | |
008 | 198512s 0 0 dut d | ||
022 | _a0028-2162 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRijken, D C | |
245 | 0 | 0 |
_a[Current developments in fibrinolytic therapy]. _h[electronic resource] |
260 |
_bNederlands tijdschrift voor geneeskunde _cSep 1985 |
||
300 |
_a1768-72 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aFibrinolysis _xdrug effects |
650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
650 | 0 | 4 |
_aGlycoproteins _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPlasminogen Activators _xantagonists & inhibitors |
650 | 0 | 4 | _aPlasminogen Inactivators |
650 | 0 | 4 |
_aTissue Plasminogen Activator _xmetabolism |
650 | 0 | 4 |
_aalpha-2-Antiplasmin _xpharmacology |
773 | 0 |
_tNederlands tijdschrift voor geneeskunde _gvol. 129 _gno. 37 _gp. 1768-72 |
|
999 |
_c3940250 _d3940250 |